New Delhi, India

Aishwarya Nilakhe

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Immunology. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aishwarya Nilakhe. Retrieved from https://idiyas.com/inventor/aishwarya-nilakhe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aishwarya Nilakhe: Innovator in GSK-3 Modulation

Introduction

Aishwarya Nilakhe is an accomplished inventor based in New Delhi, India. She has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of GSK-3 activity. Her innovative work has the potential to impact various therapeutic areas.

Latest Patents

Aishwarya holds a patent for a novel compound that modulates GSK-3 activity. The patent describes a compound of formula I, its derivatives, and pharmaceutically acceptable salts. This invention is crucial for modulating GSK3 levels, which can influence various biological processes.

Career Highlights

Aishwarya is currently associated with the National Institute of Immunology, where she conducts her research. Her work focuses on developing compounds that can effectively modulate GSK-3, contributing to advancements in medical treatments.

Collaborations

Aishwarya collaborates with notable colleagues, including Sarika Gupta and Ibrar Ahmed Siddiqui. These partnerships enhance her research efforts and foster innovation in her field.

Conclusion

Aishwarya Nilakhe's contributions to the modulation of GSK-3 activity highlight her role as a significant inventor in the pharmaceutical industry. Her innovative work continues to pave the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…